These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Periprocedural myocardial injury and infarction after myocardial revascularization: incidence, clinical features and prognosis].
    Author: Armillotta M, Angeli F, Rinaldi A, Bertolini D, Amicone S, Bodega F, Fedele D, Impellizzeri A, Di Iuorio O, Bergamaschi L, Paolisso P, Foà A, Stefanizzi A, Sansonetti A, Canton L, Suma N, Tattilo FP, Cavallo D, Ryabenko K, Casuso Alvarez M, Tortorici G, Pizzi C.
    Journal: G Ital Cardiol (Rome); 2023 Nov; 24(11):880-892. PubMed ID: 37901979.
    Abstract:
    Myocardial revascularization, either percutaneous or surgical, is the cornerstone of chronic and acute ischemic coronary artery disease therapy. Periprocedural myocardial injury and infarction are possible complications of these procedures. Several pathogenetic mechanisms have been proposed in the setting of percutaneous (distal embolism, vasospasm, obstruction of a minor vessel) or surgical revascularization (prolonged ischemic time, early graft failure, arrhythmia or severe hypotension during the procedure). High-sensitivity cardiac troponins have emerged as the recommended biomarkers due to their important prognostic implications. However, data regarding diagnostic criteria, management and prognostic implications of these complications are lacking. The present review aims to provide an overview regarding the possible diagnostic criteria, management and prognostic role of periprocedural myocardial injury and infarction.
    [Abstract] [Full Text] [Related] [New Search]